Fox Chase clinical trial tests first of its kind antibody
Friday, June 4, 2010 - 12:11
in Health & Medicine
CHICAGO, IL. (June 7, 2010) — — Patients with HER2-positive cancers can have dramatic responses to HER2-targeted drugs but eventually develop resistance to the agents. With that problem...